Citation: Ja. Balfour et Kl. Goa, DOLASETRON - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF NAUSEA AND VOMITING INDUCED BY CHEMOTHERAPY, RADIOTHERAPY OR SURGERY, Drugs, 54(2), 1997, pp. 273-298
Citation: A. Markham et Kl. Goa, VALSARTAN - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN ESSENTIAL-HYPERTENSION, Drugs, 54(2), 1997, pp. 299-311
Citation: Lr. Wiseman et Kl. Goa, TOREMIFENE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF ADVANCED BREAST-CANCER, Drugs, 54(1), 1997, pp. 141-160
Citation: Kl. Goa et al., LISINOPRIL - A REVIEW OF ITS PHARMACOLOGY AND USE IN THE MANAGEMENT OF THE COMPLICATIONS OF DIABETES-MELLITUS, Drugs, 53(6), 1997, pp. 1081-1105
Citation: Rn. Brogden et Kl. Goa, ADAPALENE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN THE MANAGEMENT OF MILD-TO-MODERATE ACNE (VOL 53, PG 511, 1997), Drugs, 53(5), 1997, pp. 827-827
Citation: Jc. Gillis et al., OCTREOTIDE LONG-ACTING RELEASE (LAR) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF ACROMEGALY, Drugs, 53(4), 1997, pp. 681-699
Citation: Kl. Goa et al., SPARFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN LOWER RESPIRATORY-TRACT INFECTIONS, Drugs, 53(4), 1997, pp. 700-725
Citation: Rn. Brogden et Kl. Goa, ADAPALENE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN THE MANAGEMENT OF MILD-TO-MODERATE ACNE, Drugs, 53(3), 1997, pp. 511-519
Citation: B. Fulton et Kl. Goa, OLANZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF SCHIZOPHRENIA AND RELATED PSYCHOSES, Drugs, 53(2), 1997, pp. 281-298
Citation: Kl. Goa et al., BEZAFIBRATE - AN UPDATE OF ITS PHARMACOLOGY AND USE IN THE MANAGEMENTOF DYSLIPIDEMIA - DRUGS (VOL 52, PG 725, 1996), Drugs, 53(1), 1997, pp. 188-188
Citation: Ap. Lea et Kl. Goa, COPOLYMER-1 - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN MULTIPLE-SCLEROSIS, CLINICAL IMMUNOTHERAPEUTICS, 6(4), 1996, pp. 319-331
Citation: A. Markham et Kl. Goa, KETOTIFEN - A REVIEW OF ITS THERAPEUTIC EFFICACY IN DERMATOLOGICAL DISORDERS, CLINICAL IMMUNOTHERAPEUTICS, 5(5), 1996, pp. 400-411
Citation: Ap. Lea et Kl. Goa, CALCIPOTRIOL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF PSORIASIS, CLINICAL IMMUNOTHERAPEUTICS, 5(3), 1996, pp. 230-248
Citation: Jc. Gillis et Kl. Goa, STREPTOKINASE - A PHARMACOECONOMIC APPRAISAL OF ITS USE IN THE MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION, PharmacoEconomics, 10(3), 1996, pp. 281-310
Citation: Cj. Dunn et Kl. Goa, ENOXAPARIN - A PHARMACOECONOMIC APPRAISAL OF ITS USE IN THROMBOEMBOLIC PROPHYLAXIS AFTER TOTAL HIP-ARTHROPLASTY, PharmacoEconomics, 10(2), 1996, pp. 179-190
Citation: Lr. Wiseman et Kl. Goa, FORMESTANE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE TREATMENT OF POSTMENOPAUSAL BREAST-CANCER, Drugs & aging, 9(4), 1996, pp. 292-306
Citation: Cj. Dunn et Kl. Goa, MITOXANTRONE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND USE IN ACUTE NONLYMPHOBLASTIC LEUKEMIA, Drugs & aging, 9(2), 1996, pp. 122-147
Citation: S. Noble et Kl. Goa, TICLOPIDINE - A REVIEW OF ITS PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY IN THE PREVENTION OF CEREBRAL-ISCHEMIA AND STROKE (VOL 8, PG214, 1996), Drugs & aging, 8(6), 1996, pp. 444-444
Citation: S. Noble et Kl. Goa, DRUG-EVALUATION - TICLOPIDINE - A REVIEW OF ITS PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY IN THE PREVENTION OF CEREBRAL-ISCHEMIA ANDSTROKE, Drugs & aging, 8(3), 1996, pp. 214-232
Citation: Cm. Spencer et Kl. Goa, IODIXANOL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND DIAGNOSTIC USE AS AN X-RAY CONTRAST-MEDIUM, Drugs, 52(6), 1996, pp. 899-927
Citation: Kl. Goa et Aj. Wagstaff, LOSARTAN POTASSIUM - A REVIEW OF ITS PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY IN THE MANAGEMENT OF HYPERTENSION (VOL 51, PG 820, 1996), Drugs, 52(4), 1996, pp. 540-540